Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Lehtiö J
JSON
CSV
XLSX
TXT
Family name
Lehtiö
Given name
Janne
Initials
J
ORCID
ORCID
0000-0002-8100-9562
Affiliations
Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden.
22 publications
PubMed
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy.
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
Elife
13
(-) - [2025-06-03; online 2025-06-03]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
Elife
13
(-) - [2025-06-03; online 2025-06-03]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-05-20; online 2025-05-20]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-03-20; online 2025-03-20]
DOI
Crossref
Author response: Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2025-03-20; online 2025-03-20]
PubMed
DOI
Crossref
Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets.
Leo IR
, Kunold E,
Audrey A
, ...,
Lehtiö J
,
Jafari R
Nat Commun
16
(1) 1948 [2025-02-25; online 2025-02-25]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2024-08-09; online 2024-08-09]
PubMed
DOI
Crossref
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.
Carmona J
,
Chavarria E
,
Donoghue K
, ...,
Zwart W
,
Tabernero J
Cancer Discov
14
(7) 1147-1153 [2024-07-01; online 2024-06-13]
DOI
Crossref
Pathway activation model for personalized prediction of drug synergy
Trac QT
, Huang Y, Erkers T, ..., Pawitan Y,
Vu TN
-
-
(-) - [2024-06-08; online 2024-06-08]
PubMed
DOI
Crossref
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Manfredi F
,
Stasi L
, Buonanno S, ...,
Bonini C
,
Ruggiero E
Sci Adv
9
(48) eadg8014 [2023-12-00; online 2023-12-01]
DOI
Crossref
Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors
Chiaro J, Antignani G,
Feola S
, ...,
Lehtiö J
,
Cerullo V
-
-
(-) - [2022-11-08; online 2022-11-08]
DOI
Crossref
Integrative multi-omics analysis reveals molecular subtypes and tumor evolution of synovial sarcoma
Chen Y
, Su Y,
Leo IR
, ..., Larsson O,
Haglund de Flon F
-
-
(-) - [2022-05-10; online 2022-05-10]
PubMed
DOI
Crossref
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.
Feola S
, Chiaro J, Martins B, ...,
Lehtiö J
,
Cerullo V
Elife
11
(-) - [2022-03-22; online 2022-03-22]
DOI
Crossref
Author response: A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Feola S
, Chiaro J, Martins B, ...,
Lehtiö J
,
Cerullo V
-
-
(-) - [2022-02-22; online 2022-02-22]
DOI
Crossref
Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures
Babačić H
, Galardi S,
Umer HM
, ..., Ciafrè SA,
Pernemalm M
-
-
(-) - [2022-02-10; online 2022-02-10]
DOI
Crossref
Generation of ENSEMBL-based proteogenomics databases boosts the identification of non-canonical peptides
Umer HM
,
Zhu Y
,
Pfeuffer J
, ...,
Branca R
,
Perez-Riverol Y
-
-
(-) - [2021-06-09; online 2021-06-09]
PubMed
DOI
Crossref
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.
Brunner A
,
Suryo Rahmanto A
, Johansson H, ...,
Larsson LG
,
Sangfelt O
Elife
9
(-) - [2020-07-06; online 2020-07-06]
DOI
Crossref
Author response: PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
Brunner A
,
Suryo Rahmanto A
, Johansson H, ...,
Larsson LG
,
Sangfelt O
-
-
(-) - [2020-06-22; online 2020-06-22]
PubMed
DOI
Crossref
Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model.
Levitsky A
,
Pernemalm M
, Bernhardson BM, ..., Tishelman C,
Eriksson LE
Sci Rep
9
(1) 16504 [2019-11-11; online 2019-11-11]
PubMed
DOI
Crossref
Author Correction: Extracellular nanovesicles released from the commensal yeast Malassezia sympodialis are enriched in allergens and interact with cells in human skin.
Johansson HJ
, Vallhov H, Holm T, ...,
Lehtiö J
, Scheynius A
Sci Rep
9
(1) 15014 [2019-10-15; online 2019-10-15]
PubMed
DOI
Crossref
In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta.
Pernemalm M
, Sandberg A, Zhu Y, ..., Westgren M,
Lehtiö J
Elife
8
(-) - [2019-04-08; online 2019-04-08]
DOI
Crossref
Author response: In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta
Pernemalm M
, Sandberg A, Zhu Y, ..., Westgren M,
Lehtiö J
-
-
(-) - [2019-02-13; online 2019-02-13]
SciLifeLab Data Centre
Publications
9.5.1